Cargando…
tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas
Autores principales: | Hoshino, M, Haraguchi, Y, Sakai, M, Saegusa, H, Hayashi, E, Horita , N, Ohsawa, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301804/ http://dx.doi.org/10.1186/cc476 |
Ejemplares similares
-
Close relationship of tissue plasminogen activator-plasminogen
activator inhibitor-1 complex with multiple organ dysfunction syndrome
investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001) -
Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (1998) -
Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2001) -
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015) -
Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)